
The following hypothesis is proposed: BMSC-Exos act on intestinal cells, upregulating and regulating endogenous ACSF2 expression, enhancing mitochondrial fatty acid activation and promoting mitochondrial β-oxidation (FAO), thereby improving mitochondrial function, reducing ROS levels, and inhibiting the NF-κB inflammatory pathway, ultimately promoting intestinal mucosal repair and achieving a therapeutic effect on Crohn's disease. Based on this and previous conversations, could you help me create a schematic diagram of the research effects and hypotheses?
Chart Type: Waterfall Chart Data and Visual Design: 1. Sta...